Evidence map›Paper›PMID 26083725›Full record

ArticlePloS one2015

Protein Corona Prevents TiO2 Phototoxicity.

Maja Garvas, Anze Testen, Polona Umek, Alexandre Gloter, Tilen Koklic, Janez Strancar

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Low doses of TiOScience and technology of advanced materials · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Maja GarvasJožef Stefan Institute, Ljubljana, Slovenia; Jožef Stefan International Postgraduate School, Ljubljana, Slovenia.
Anze TestenNAMASTE Center of Excellence, Ljubljana, Slovenia.
Polona UmekJožef Stefan Institute, Ljubljana, Slovenia; NAMASTE Center of Excellence, Ljubljana, Slovenia.
Alexandre GloterLaboratoire de Physique des Solides, Université Paris Sud, CNRS UMR 8502, F-91405, Orsay, France.
Tilen KoklicJožef Stefan Institute, Ljubljana, Slovenia; NAMASTE Center of Excellence, Ljubljana, Slovenia.
Janez StrancarJožef Stefan Institute, Ljubljana, Slovenia; NAMASTE Center of Excellence, Ljubljana, Slovenia.
Centre of Excellence NAMASTE · SIJožef Stefan Institute · SIUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

aimTiO2 nanoparticles have generally low toxicity in the in vitro systems although some toxicity is expected to originate in the TiO2-associated photo-generated radical production, which can however be modulated by the radical trapping ability of the serum proteins. To explore the role of serum proteins in the phototoxicity of the TiO2 nanoparticles we measure viability of the exposed cells depending on the nanoparticle and serum protein concentrations. METHODS &

resultsFluorescence and spin trapping EPR spectroscopy reveal that the ratio between the nanoparticle and protein concentrations determines the amount of the nanoparticles' surface which is not covered by the serum proteins and is proportional to the amount of photo-induced radicals. Phototoxicity thus becomes substantial only at the protein concentration being too low to completely coat the nanotubes' surface.

conclusionThese results imply that TiO2 nanoparticles should be applied with ligands such as proteins when phototoxic effects are not desired - for example in cosmetics industry. On the other hand, the nanoparticles should be used in serum free medium or any other ligand free medium, when phototoxic effects are desired - as for efficient photodynamic cancer therapy.

Indexed as

AnimalsBlood ProteinsCattleCell LineCell SurvivalHumansNanoparticlesPhotochemical ProcessesProtein CoronaReactive Oxygen SpeciesTitaniumUltraviolet RaysBlood ProteinsProtein CoronaReactive Oxygen SpeciesTitaniumtitanium dioxide

Identifiers

PMID26083725
PMCPMC4470505
OpenAlexW2124763700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.